BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7439477)

  • 1. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC; Mitchell AJ; Swanson NA; Vanderveen EE; Ellis CN; Headington JT
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
    Valsecchi R; Pansera B; Rossi A; Cainelli T
    G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of alopecia areata-like hair loss with the contact sensitizer squaric acid dibutylester (SADBE) in C3H/HeJ mice.
    Freyschmidt-Paul P; Sundberg JP; Happle R; McElwee KJ; Metz S; Boggess D; Hoffmann R
    J Invest Dermatol; 1999 Jul; 113(1):61-8. PubMed ID: 10417620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G; Cicero RL; Nasca MR; Sapuppo A
    Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNCB therapy of alopecia areata].
    Happle R
    Z Hautkr; 1979 May; 54(10):426-9. PubMed ID: 314203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alopecia areata with squaric acid dibutylester.
    Caserio RJ
    Arch Dermatol; 1987 Aug; 123(8):1036-41. PubMed ID: 3307636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical squaric acid dibutylester therapy for alopecia areata: a double-sided patient-controlled study.
    Chua SH; Goh CL; Ang CB
    Ann Acad Med Singap; 1996 Nov; 25(6):842-7. PubMed ID: 9055014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe alopecia areata with squaric acid dibutylester in pediatric patients.
    Orecchia G; Malagoli P; Santagostino L
    Pediatr Dermatol; 1994 Mar; 11(1):65-8. PubMed ID: 8170854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dinitrochlorobenzene therapy for alopecia areata.
    Happle R; Cebulla K; Echternacht-Happle K
    Arch Dermatol; 1978 Nov; 114(11):1629-31. PubMed ID: 152611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R; Cainelli T; Tornaghi A; Rossi A; Perego GB; Smojver E; Panunzio M
    Clin Exp Dermatol; 1985 May; 10(3):233-8. PubMed ID: 4006285
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical squaric acid dibutylester therapy for alopecia areata.
    Flowers FP; Slazinski L; Fenske NA; Pullara TJ
    Cutis; 1982 Dec; 30(6):733-6. PubMed ID: 6756800
    [No Abstract]   [Full Text] [Related]  

  • 15. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical immunotherapy in alopecia areata.
    Singh G; Lavanya M
    Int J Trichology; 2010 Jan; 2(1):36-9. PubMed ID: 21188022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DNCB therapy for alopecia areata (author's transl)].
    Zisiadis S; Wüthrich B; Schnyder UW
    Dermatologica; 1980; 161(6):365-71. PubMed ID: 7215615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical immunotherapy of alopecia areata. A follow-up study.
    Valsecchi R; Cainelli T; Foiadelli L; Rossi A
    Acta Derm Venereol; 1986; 66(3):269-72. PubMed ID: 2426909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nickel sensitivity as a complication of squaric acid dibutylester treatment of alopecia areata.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1985 Apr; 12(4):234. PubMed ID: 4017578
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent allergic contact dermatitis at the site of primary sensitization with squaric acid dibutyl ester.
    Nasca MR; Cicero RL; Innocenzi D; Micali G
    Contact Dermatitis; 1995 Dec; 33(6):438. PubMed ID: 8706413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.